[{"Assets_0_Q3_USD":4558128000.0,"CommonStockSharesOutstanding_0_Q3_shares":179604381.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-9081000.0,"NetIncomeLoss_1_Q3_USD":55036000.0,"NetIncomeLoss_3_Q3_USD":-38872000.0,"StockholdersEquity_0_Q3_USD":3074405000.0,"EarningsPerShareBasic_1_Q3_USD":0.31,"EarningsPerShareBasic_3_Q3_USD":-0.22,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":179289000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":178873000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191029"}]